Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,467 INR | -1.28% | +1.22% | -0.33% |
Business Summary
Number of employees: 1,180
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredients
89.2
%
| 5,749 | 80.6 % | 7,613 | 89.2 % | +32.42% |
Formulations
10.8
%
| 1,380 | 19.4 % | 919 | 10.8 % | -33.45% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
50.7
%
| 3,392 | 47.6 % | 4,321 | 50.7 % | +27.40% |
Others
32.1
%
| 2,423 | 34.0 % | 2,738 | 32.1 % | +13.00% |
America
17.3
%
| 1,315 | 18.4 % | 1,473 | 17.3 % | +12.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ankur Vaid
CEO | Chief Executive Officer | 42 | 04/09/04 |
Sudhir Vaid
CEO | Chief Executive Officer | 71 | 10/00/10 |
Lalit Sethi
DFI | Director of Finance/CFO | 58 | 14/22/14 |
Prakash Sajnani
CMP | Compliance Officer | - | 15/06/15 |
Subhash Nair
PRN | Corporate Officer/Principal | - | 10/17/10 |
Manoj Kumar
PRN | Corporate Officer/Principal | - | - |
Devang Bhatt
SAM | Sales & Marketing | - | 10/05/10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 24/22/24 | |
Director/Board Member | 79 | 31/17/31 | |
Bharti Khanna
BRD | Director/Board Member | 56 | 31/17/31 |
Sudhir Vaid
CEO | Chief Executive Officer | 71 | 10/00/10 |
Ankur Vaid
CEO | Chief Executive Officer | 42 | 04/09/04 |
Ravi N. Kapoor
BRD | Director/Board Member | 60 | 15/03/15 |
Jayaram Easwaran
BRD | Director/Board Member | 71 | 14/22/14 |
Director/Board Member | 78 | 14/22/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 104,616,000 | 25,956,544 ( 24.81 %) | 0 | 24.81 % |
Company contact information
Concord Biotech Ltd.
B-Wing, Mondeal Heights Iscon Cross Road, S.G. Highway
380015, Ahmedabad
+91 79 6813 8700
http://www.concordbiotech.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.33% | 186.43Cr | |
+0.99% | 9.17TCr | |
0.00% | 3.94TCr | |
-9.09% | 3.45TCr | |
+65.53% | 2.67TCr | |
-18.10% | 1.51TCr | |
-5.97% | 1.33TCr | |
-10.69% | 1.17TCr | |
-47.78% | 1.05TCr | |
+8.09% | 941.14Cr |
- Stock Market
- Equities
- CONCORDBIO Stock
- Company Concord Biotech Limited